Sotagliflozin adjunct treatment improves A1c and lowers hypoglycemia in type 1 Diabetes


eMediNexus    03 July 2018

Findings of a new study presented June 24, 2018 at the 78th Scientific Sessions of the American Diabetes Association in Orlando, Florida show that addition of sotagliflozin 200/400 mg to optimized insulin therapy lowers HbA1c, body weight and the incidence of severe hypoglycemia after a year of treatment in patients with type 1 diabetes.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.